SEC Form 4 · accession 0001144204-15-071302
TITAN PHARMACEUTICALS INC · TTNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eurelio M Cavalier
Director
Period of report
Dec 14, 2015
Accepted (ET)
Dec 16, 2015 · 5:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000910267
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock | $5.10 | Dec 14, 2015 | A | 10,000 | A | Dec 14, 2015 | Dec 14, 2025 | Common Stock | 10,000 | 10,000 | D |